Companies Dominating the High-flow Nasal Cannula Landscape
- Armstrong Medical Ltd
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Eakin Healthcare Group
- ResMed Corp.
- Teleflex Incorporated
- Vapotherm, Inc.
- Becton, Dickinson, and Company
- Smiths Group plc
- CU Medical Systems, Inc
- Flexicare Medical Limited
- TEIJIN LIMITED
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Currently in 2025, the industry revenue of high-flow nasal cannula is assessed at USD 12.21 billion.
The global high-flow nasal cannula market is expected to rise from USD 11.26 billion in 2024 to USD 49.13 billion by 2037, witnessing a CAGR of over 12% throughout the forecast period, between 2025 and 2037.
Asia Pacific industry is estimated to dominate majority revenue share by 2037, due to growing geriatric and pediatric population, along with the increasing prevalence of asthma in the region.
The major players in the market include Armstrong Medical Ltd, Eakin Healthcare Group, ResMed Corp., Teleflex Incorporated, Vapotherm, Inc., Becton, Dickinson, and Company, Smiths Group plc, CU Medical Systems, Inc, Flexicare Medical Limited, TEIJIN LIMITED.
